BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of a butyrate-fortified milk replacer on gastrointestinal microbiota and products of fermentation in artificially reared dairy calves at weaning. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 14901 Pub: 2018 Oct 8 Epub: 2018 Oct 8 Authors O`Hara E , Kelly A , McCabe MS , Kenny DA , Guan LL , Waters SM , |
|
|
Effect of Low Protein Diets Supplemented with Sodium Butyrate, Medium-Chain Fatty Acids, or n-3 Polyunsaturated Fatty Acids on the Growth Performance, Immune Function, and Microbiome of Weaned Piglets. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 24 Pages: Pub: 2023 Dec 18 Epub: 2023 Dec 18 Authors Li W , Lan T , Ding Q , Ren Z , Tang Z , Tang Q , Peng X , Xu Y , Sun Z , |
|
|
Sodium butyrate administration improves intestinal development of suckling lambs. ✅
Go to Publication ✅
Journal of animal science (J Anim Sci ) Vol: 102 Issue Pages: Pub: 2024 Jan 3 Epub: Authors Sun M , Ji W , Ye H , Cai Y , Yun Y , Wei X , Wang C , Mao H , |
|
|
Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 13 Issue 24 Pages: Pub: 2023 Dec 8 Epub: 2023 Dec 8 Authors Yang T , Sun Y , Dai Z , Liu J , Xiao S , Liu Y , Wang X , Yang S , Zhang R , Yang C , Dai B , |
|
|
Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 13 Issue 24 Pages: Pub: 2023 Dec 8 Epub: 2023 Dec 8 Authors Yang T , Sun Y , Dai Z , Liu J , Xiao S , Liu Y , Wang X , Yang S , Zhang R , Yang C , Dai B , |
|
|
Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 26 Issue 12 Pages: Pub: 2025 Jun 10 Epub: 2025 Jun 10 Authors Mitrovic M , Stankovic Popovic V , Erceg S , Perišic Mitrovic M , Dobrosavljevic A , Stupar A , Vukovic P , Zlatkovic D , Svorcan P , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
